Elizabeth Y.

Elizabeth Y. has over 20 years of experience in regulatory affairs and pharmaceutical research. Currently, Elizabeth serves as Manager of Global Regulatory Affairs for New Products at medac GmbH, focusing on regulatory issues for new products globally since May 2020. Prior roles include Manager of Global Regulatory Operations and Project Manager of Drug Regulatory Affairs at medac GmbH, as well as positions at Almirall Hermal GmbH and EA Young Regulatory Affairs, where Elizabeth provided independent regulatory consultation and prepared regulatory applications. With a solid foundation in research as a Senior Research Scientist at AstraZeneca and Parke-Davis, Elizabeth has a robust educational background including a Ph.D. in insulin receptors, a Master's in Neuroscience, and a Bachelor's in Biological Sciences from prestigious institutions. Key skills encompass regulatory strategy, compliance, and extensive knowledge in pharmacological research and drug development processes.